Literature DB >> 23108654

Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.

Brett L Jennings1, Anne M Estes, Larry J Anderson, Xiao R Fang, Fariborz A Yaghini, Zheng Fan, Frank J Gonzalez, William B Campbell, Kafait U Malik.   

Abstract

Previously, we showed that the cytochrome P450 1B1 inhibitor 2,3',4,5'-tetramethoxystilbene reversed deoxycorticosterone acetate (DOCA)-salt-induced hypertension and minimized endothelial and renal dysfunction in the rat. This study was conducted to test the hypothesis that cytochrome P450 1B1 contributes to cardiac dysfunction, and renal damage and inflammation associated with DOCA-salt-induced hypertension, via increased production of reactive oxygen species and modulation of neurohumoral factors and signaling molecules. DOCA-salt increased systolic blood pressure, cardiac and renal cytochrome P450 1B1 activity, and plasma levels of catecholamines, vasopressin, and endothelin-1 in wild-type (Cyp1b1(+/+)) mice that were minimized in Cyp1b1(-/-) mice. Cardiac function, assessed by echocardiography, showed that DOCA-salt increased the thickness of the left ventricular posterior and anterior walls during diastole, the left ventricular internal diameter, and end-diastolic and end-systolic volume in Cyp1b1(+/+) but not in Cyp1b1(-/-) mice; stroke volume was not altered in either genotype. DOCA-salt increased renal vascular resistance and caused vascular hypertrophy and renal fibrosis, increased renal infiltration of macrophages and T lymphocytes, caused proteinuria, increased cardiac and renal nicotinamide adenine dinucleotide phosphate-oxidase activity, caused production of reactive oxygen species, and increased activities of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase, and cellular-Src; these were all reduced in DOCA-salt-treated Cyp1b1(-/-) mice. Renal and cardiac levels of eicosanoids were not altered in either genotype of mice. These data suggest that, in DOCA-salt hypertension in mice, cytochrome P450 1B1 plays a pivotal role in cardiovascular dysfunction, renal damage, and inflammation, and increased levels of catecholamines, vasopressin, and endothelin-1, consequent to generation of reactive oxygen species and activation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase, and cellular-Src independent of eicosanoids.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108654      PMCID: PMC3499668          DOI: 10.1161/HYPERTENSIONAHA.112.202606

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  57 in total

1.  Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research.

Authors:  Theodore W Kurtz; Karen A Griffin; Anil K Bidani; Robin L Davisson; John E Hall
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

Review 2.  Endothelin, angiotensin, and oxidative stress in hypertension.

Authors:  David M Pollock
Journal:  Hypertension       Date:  2005-02-21       Impact factor: 10.190

Review 3.  Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.

Authors:  John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2005-09

4.  Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.

Authors:  Tzu-Hurng Cheng; Neng-Lang Shih; Cheng-Hsien Chen; Heng Lin; Ju-Chi Liu; Hung-Hsing Chao; Jer-Young Liou; Yen-Ling Chen; Hsing-Wen Tsai; Yee-Shiuan Chen; Ching-Feng Cheng; Jin-Jer Chen
Journal:  J Biomed Sci       Date:  2005       Impact factor: 8.410

5.  Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats.

Authors:  Manuel Sánchez; Milagros Galisteo; Rocío Vera; Inmaculada C Villar; Antonio Zarzuelo; Juan Tamargo; Francisco Pérez-Vizcaíno; Juan Duarte
Journal:  J Hypertens       Date:  2006-01       Impact factor: 4.844

6.  Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats.

Authors:  L Jin; R A Beswick; T Yamamoto; T Palmer; T A Taylor; J S Pollock; D M Pollock; M W Brands; R C Webb
Journal:  J Physiol Pharmacol       Date:  2006-09       Impact factor: 3.011

7.  Redox dependence of glomerular epithelial cell hypertrophy in response to glucose.

Authors:  Nam-Ho Kim; Hernan Rincon-Choles; Basant Bhandari; Goutam Ghosh Choudhury; Hanna E Abboud; Yves Gorin
Journal:  Am J Physiol Renal Physiol       Date:  2005-10-18

8.  Differential activation of mitogenic signaling pathways in aortic smooth muscle cells deficient in superoxide dismutase isoforms.

Authors:  Nageswara R Madamanchi; Sung-Kwon Moon; Zeenat S Hakim; Shantres Clark; Ali Mehrizi; Cam Patterson; Marschall S Runge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-03       Impact factor: 8.311

9.  Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.

Authors:  Carolina De Ciuceis; Farhad Amiri; Pascal Brassard; Dierk H Endemann; Rhian M Touyz; Ernesto L Schiffrin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-11       Impact factor: 8.311

10.  Potassium supplementation reduces cardiac and renal hypertrophy independent of blood pressure in DOCA/salt mice.

Authors:  Qing Wang; Andrea A Domenighetti; Thierry Pedrazzini; Michel Burnier
Journal:  Hypertension       Date:  2005-08-15       Impact factor: 10.190

View more
  11 in total

1.  6β-hydroxytestosterone, a cytochrome P450 1B1 metabolite of testosterone, contributes to angiotensin II-induced hypertension and its pathogenesis in male mice.

Authors:  Ajeeth K Pingili; Mehmet Kara; Nayaab S Khan; Anne M Estes; Zongtao Lin; Wei Li; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2015-04-13       Impact factor: 10.190

Review 2.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

3.  CYP1B1 deficiency ameliorates obesity and glucose intolerance induced by high fat diet in adult C57BL/6J mice.

Authors:  Xiaocong Liu; Tingting Huang; Lu Li; Yumeng Tang; Yatao Tian; Suqing Wang; Cuifang Fan
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

Review 4.  Potential role of CYP1B1 in the development and treatment of metabolic diseases.

Authors:  Fei Li; Weifeng Zhu; Frank J Gonzalez
Journal:  Pharmacol Ther       Date:  2017-03-16       Impact factor: 12.310

5.  The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.

Authors:  Zaid H Maayah; Hassan N Althurwi; Ahmed A El-Sherbeni; Ghada Abdelhamid; Arno G Siraki; Ayman O S El-Kadi
Journal:  Mol Cell Biochem       Date:  2017-03-01       Impact factor: 3.396

6.  Estrogen metabolism by cytochrome P450 1B1 modulates the hypertensive effect of angiotensin II in female mice.

Authors:  Brett L Jennings; L Watson George; Ajeeth K Pingili; Nayaab S Khan; Anne M Estes; Xiao R Fang; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2014-04-28       Impact factor: 10.190

7.  Cytochrome P450 1B1 contributes to increased blood pressure and cardiovascular and renal dysfunction in spontaneously hypertensive rats.

Authors:  Brett L Jennings; David E Montanez; Michael E May; Anne M Estes; Xiao R Fang; Fariborz A Yaghini; Alie Kanu; Kafait U Malik
Journal:  Cardiovasc Drugs Ther       Date:  2014-04       Impact factor: 3.727

8.  Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment.

Authors:  Xing-Lin Tan; Yue-Qiang Xue; Tao Ma; Xiaofang Wang; Jing Jing Li; Lubin Lan; Kafait U Malik; Michael P McDonald; Alejandro M Dopico; Francesca-Fang Liao
Journal:  Mol Neurodegener       Date:  2015-06-24       Impact factor: 14.195

9.  Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice.

Authors:  Chi Young Song; Khuzema Ghafoor; Hafiz U Ghafoor; Nayaab S Khan; Shyamala Thirunavukkarasu; Brett L Jennings; Anne M Estes; Sahar Zaidi; Dave Bridges; Patrick Tso; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

10.  Attenuation of Angiotensin II-Induced Hypertension in BubR1 Low-Expression Mice Via Repression of Angiotensin II Receptor 1 Overexpression.

Authors:  Yukihiko Aoyagi; Tadashi Furuyama; Kentaro Inoue; Daisuke Matsuda; Yutaka Matsubara; Arihide Okahara; Tetsuro Ago; Yutaka Nakashima; Masaki Mori; Takuya Matsumoto
Journal:  J Am Heart Assoc       Date:  2019-11-30       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.